Zinc-induced tolerance to cadmium hepatotoxicity.
Pretreatment with Zn is known to produce tolerance to several toxic effects of Cd. This study was designed to determine if zinc pretreatment decreased Cd-induced lethality and hepatotoxicity. Rats given 4.0 mg Cd/kg, iv, died within 10 to 20 hr while there was no mortality in rats pretreated with Zn (12 mg Zn/kg, sc, 48 and 24 hr prior to Cd challenge). Ten hr after Cd, plasma aspartate aminotransferase and sorbitol dehydrogenase activities were markedly elevated and extensive histopathologic lesions of the liver were evident in control rats while such injury was not evident in Zn-pretreated rats. To examine the mechanism of this tolerance, distribution of Cd to 14 organs and the subcellular distribution in 6 organs (liver, kidneys, intestines, heart, spleen, and testes) was determined in control and Zn-pretreated rats. Two hours after challenge (3.5 mg Cd/kg, iv, 7 microCi 109Cd/mg Cd), the distribution of Cd to the liver markedly increased after Zn pretreatment without concomitant decreases in other tissues. Zn pretreatment resulted in distribution of more Cd to hepatic cytosol and less associated with endoplasmic reticulum. Gel filtration chromatography indicated that most cytosolic Cd was bound to metallothionein. These data suggest that Zn pretreatment reduces Cd-induced hepatotoxicity which prevents the lethal effects of Cd possibly by altering the hepatic subcellular distribution of Cd.
D000704:Analysis of Variance; D000818:Animals; D001219:Aspartate Aminotransferases / Q000378:metabolism; D002104:Cadmium / Q000378:metabolism / Q000633:toxicity*; D004347:Drug Interactions; D007064:L-Iditol 2-Dehydrogenase / Q000378:metabolism; D008099:Liver / Q000187:drug effects* / Q000473:pathology; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D014018:Tissue Distribution; D015032:Zinc / Q000494:pharmacology*
D002104:Cadmium; D007064:L-Iditol 2-Dehydrogenase; D001219:Aspartate Aminotransferases; D015032:Zinc